Jump to section
Sanity Group's mission is to unlock the benefits of cannabis for health and wellbeing and make them widely accessible to people in Europe.
25% employee growth in 12 months
The global CBD market is booming and is expected to grow to $19.5 billion by 2025. The pharmaceutical channel is estimated to account for about 12% of this market, and with a rapidly growing body of science demonstrating the many health benefits of cannabinoids, there is all the more reason to suggest that this industry will continue to rise over the coming decade.
Sanity Group is a cannabis and digital health startup aiming to unlock the health benefits of cannabinoids for the European market. With a focus on creating innovative cannabinoid-based pharmaceuticals and wellbeing products, Sanity Group will be pioneering their use in Europe and hoping to bring it into the mainstream consumer market.
Investor interest is big, and following significant funding across numerous rounds, Sanity Group is currently focused on expanding its medical division in Europe as well as developing new research and production facilities.
Steph
Company Specialist at Welcome to the Jungle
Jun 2024
$12.4m
CONVERTIBLE
Sep 2022
$37.6m
SERIES B
Finn Age Hänsel
(Managing Director)A serial entrepreneur and business angel, Finn has been a mentor at TECHSTARTS since 2015, and also co-founded Berliner Berg, a craft beer brewery.
Fabian Friede
(Advisor)Ex-CMO of Locafox, Fabian also founded Kununu Engage in 2017, and has been a business angel with Samsarik Capital since 2018.